Nanoparticles Deliver Hydrogen Gas Into Tumors in Mice
Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy
Research hubs: Immune System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (mouse)
- Authors
- Yongju He, Xiangjie Tian, Xingyu Fan, Xiyu Gong, Songwen Tan, Anqiang Pan, Shuquan Liang, Hui Xu, Fangfang Zhou
- Journal
- ACS Applied Materials & Interfaces
- Year
- 2023
- PMID
- 36594282
- Study Type
- Mouse
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 34 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Scientists have created tiny, smart nanoparticles that can safely deliver hydrogen gas deep into tumors to effectively slow down their growth without harming normal tissues.
Key Finding
An enzyme-responsive nanoparticle system successfully delivered hydrogen gas to deep tumor regions in mice, achieving significant tumor growth suppression without toxicity to normal tissues.
Summary
Researchers developed a tiny nanoparticle system designed to deliver hydrogen gas deep into tumors in mice. The nanoparticles are coated with a protein that breaks down in the acidic tumor environment, releasing hydrogen gas that can penetrate far into tumor tissue. In mouse studies, this approach slowed tumor growth without harming healthy tissue, suggesting hydrogen gas therapy might be a safer alternative to traditional chemotherapy.
Practical Takeaway
This is early-stage research in mice using a specialized nanoparticle delivery system—not a study of hydrogen water as a consumer product. While the results are promising for future cancer therapies, it is far too early to draw conclusions about hydrogen water's effects on human health or tumors. Much more research, including human trials, would be needed before any clinical applications.
Abstract (excerpt)
The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side…